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Abstract
Background: Hospital-based discharge registries are used increasingly for longitudinal
epidemiological studies of HIV. We examined completeness of registration of HIV infections and
of chronic hepatitis B (HBV) and hepatitis C (HCV) coinfections in the Danish National Hospital
Registry (DNHR) covering all Danish hospitals.
Methods: The Danish HIV Cohort Study (DHCS) encompasses all HIV-infected patients treated
in Danish HIV clinics since 1 January 1995. All 2,033 Danish patients in DHCS diagnosed with HIV-
1 during the 10-year period from 1 January 1995 to 31 December 2004 were included in the
current analysis. We used the DHCS as a reference to examine the completeness of HIV and of
HBV and HCV coinfections recorded in DNHR. Cox regression analysis was used to estimate
hazard ratios of time to diagnosis of HIV in DNHR compared to DHCS.
Results: Of the 2,033 HIV patients in DHCS, a total of 2,006 (99%) were registered with HIV in
DNHR. Of these, 1,888 (93%) were registered in DNHR within one year of their first positive HIV
test. A CD4 < 200 cells/µl, a viral load >= 100,000 copies/ml and being diagnosed after 1 January
2000, were associated with earlier registration in DNHR, both in crude and adjusted analyses.
Thirty (23%) HIV patients registered with chronic HBV (n = 129) in DHCS and 126 (48%) of HIV
patients with HCV (n = 264) in DHCS were registered with these diagnoses in the DNHR. Further
17 and 8 patients were registered with HBV and HCV respectively in DNHR, but not in DHCS.
The positive predictive values of being registered with HBV and HCV in DHCS were thereby
estimated to 0.88 and 0.97 and in DNHR to 0.32 and 0.54.
Conclusion: The study demonstrates that secondary data from national hospital databases may
be reliable for identification of patients diagnosed with HIV infection. However, the predictive value
of co-morbidity data may be low.
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Since the first AIDS cases were reported, AIDS and HIV
infection have been the subject of a wide spectrum of epi-
demiologic studies [1-3]. The characteristics of HIV infec-
tion make it both ideal and highly relevant for
epidemiological research: valid diagnostic tools, well-
described risk factors, unambiguous disease outcomes, a
high impact on morbidity and mortality, worldwide dis-
semination, and huge economic consequences com-
manding the attention of national and international
leaders.
During recent decades, patient registration in computer-
ized hospital database systems has become common [1].
Although they are not designed primarily for epidemio-
logical studies, such hospital-based registries are often
used as a quick, convenient way to create huge datasets for
epidemiological studies of multiple outcomes [4,5]. How-
ever their data may not always be entirely accurate or com-
plete.
Due to shared routes of infection, many HIV-infected
patients are coinfected with hepatitis B (HBV) or hepatitis
C (HCV). Coinfection with these viruses, especially with
HCV, is a strong prognostic marker for effectiveness of
antiretroviral treatment [6,7]. Furthermore, HBV and
HCV coinfection may influence the timing and choice of
antiretroviral treatment. In prognostic studies of HIV, it is
thus important to include HBV and HCV status, both to
predict prognosis in patient subgroups [8] and to adjust
for confounding [9].
The present study quantified the completeness of registra-
tion of diagnoses of HIV infection and of chronic HBV
and HCV coinfections in the Danish National Hospital
Registry (DNHR), based on a comparison with data col-
lected by the Danish HIV Cohort Study (DHCS).
Methods
Setting
As of 1 January 2007 Denmark had a population of
5,447,084 (Statistics Denmark), with an estimated HIV
prevalence of 0.07% among adults [10]. Medical care,
including antiretroviral treatment, is tax-paid and pro-
vided free-of-charge to all HIV-infected residents of Den-
mark. Treatment of HIV infection is restricted to eight
specialized medical centres, where patients are seen on an
outpatient basis at intended intervals of 12 weeks. During
our study's follow-up period, national criteria for initiat-
ing highly active antiretroviral treatment (HAART) were
HIV-related disease, acute HIV infection, pregnancy, CD4
cell count < 300 cells/µl, and, until 2001, plasma HIV-
RNA > 100,000 copies/ml.
Study population and data collection
Study subjects
DHCS encompasses all HIV-infected patients treated in
the above described Danish HIV clinics since 1 January
1995. Patients are identified from the lists of HIV patients
in the eight medical centres, as well as from local data-
sources in these centers of patients tested for HIV RNA
and/or CD4 cell counts. Because HIV patients undergo
tests for HIV-RNA and CD4 count in the centers at least
once a year, the risk of DHCS failing to capture HIV-
infected patients seen in the centres is negligible. Further
the fact that antiretroviral treatment is in Denmark
restricted to these eight clinics ensures that very few
patients diagnosed with HIV remains unrecognised by
DHCS. In Denmark treatment with antiretroviral drugs is
restricted to the eight medical centers participating in
DHCS. DHCS has been described elsewhere [10]. The date
of HIV diagnosis, dates of AIDS-defining diseases and
HBV and HCV status, are registered for each patient in
DHCS as well as AIDS defining events, antiretroviral treat-
ment, HIV-RNA, CD4 counts etc. The data in DHCS are
updated on a yearly basis by research nurses or physicians.
HBV and HCV status are reviewed by a trained physician
or study nurse at the centres to ensure data quality.
The present study includes all 2,033 DHCS patients who
met the following criteria: residence in Denmark at diag-
nosis (i.e., recorded in the Danish Civil Registration Sys-
tem), diagnosed with HIV after 31 January 1994 and
before 1 January 2005, and age 16 years or older at time
of diagnosis. Patients positive for the hepatitis-B S antigen
on screening are categorised as having chronic HBV in
DHCS. Patients positive for HCV serology and/or with
positive HCV RNA are categorised as HCV patients.
DNHR
Hospitalisation data for study subjects were obtained
from DNHR, which was established in 1977 mainly for
administrative and management purposes [11]. This reg-
istry includes primary diagnosis as well as co-morbidities
[ICD-8 codes until the end of 1993, ICD-10 codes there-
after (ICD-9 has never been used in Denmark)] and pro-
cedure codes for patients treated in Danish hospitals.
Diagnoses are coded by the hospital physicians at dis-
charge for inpatients and at the initial consultation for the
outpatients. Starting on 1 January 1995, the registry was
expanded to include outpatients. As the current study is
limited to patients diagnosed after 31 December 1994,
only ICD-10 codes were relevant. The first date on which
a patient was admitted to or seen as an outpatient at a
Danish hospital with one of the following diagnosis codes
was defined as the DNHR diagnosis date:
HIV: B20.0-B24.9Page 2 of 7
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Chronic hepatitis C: B18.2
In a sensitivity analysis we expanded these groups to
include nonspecific viral hepatitis as follows:
Chronic hepatitis B and nonspecific chronic viral hepati-
tis: B18.0, B18.1, B18.8, B18.9
Chronic hepatitis C and nonspecific chronic viral hepati-
tis: B18.2, B18.8, B18.9
Statistical analysis
The numbers of study patients registered with HIV in
DNHR and with HBV or HCV coinfection in DNHR and
in DHCS were determined. We calculated the complete-
ness (as a measure of sensitivity) of DNHR data as the
number of HIV patients recorded with a diagnosis in
DNHR divided by the number of patients registered with
the diagnosis in DHCS (the reference) [12]. We were not
able to compute the predictive value of a HIV diagnosis in
the DNHR since we did not have permission from the
Danish Data Protection Agency to identify HIV cases
recorded only in the DNHR.
Kaplan-Meier analyses were used to construct time-to-
event curves. Time was calculated as time elapsed from the
DHCS HIV diagnosis date to the registration date of the
first HIV diagnosis in DNHR. For patients not registered
with HIV in DNHR, time was calculated from the DHCS
date of HIV diagnosis to death or to 1 January 2007 (date
of last observation in DNHR), whichever came first. [No
one was diagnosed with HIV after death in either DNHR
or DHCS]. In a few cases the patient was registered with
HIV in DNHR before the diagnosis was registered in
DHCS, which would give negative time in time to event
analysis. In these cases for technically reasons time from
registration in DHCS to registration in DNHR was defined
to zero.
Cox regression analysis was used to estimate hazard ratios
(HR) as a measure of the relative risk of being registered
with an HIV diagnosis in DNHR. The assumption of pro-
portional hazards was assessed graphically. Age (> 40
years vs. <= 40 years), CD4 count (>= 200 vs. < 200 cells/
µl) and HIV-RNA (>= 105 vs. < 105 copies/ml) at diagno-
sis, gender, route of infection, centre and calendar time
(diagnosed before vs. on or after 1 January 2000) were
included in the analysis as categorical variables.
Patients registered in DNHR within three months of the
date of their first HIV diagnosis according to DHCS were
categorized as early registrations. Patients registered in
DNHR more than three months after DHCS registration
were considered late registrations. The mortality rate ratio
(MRR) for the post three-month period was calculated for
this group compared with the patients diagnosed later.
Data analysis was performed using SPSS statistical soft-
ware, Version 15.0 (Norusis; SPSS Inc., Chicago, Illinois,
USA). The study was approved by the Danish Data Protec-
tion Agency.
Results
Our study included the 2,033 Danish patients diagnosed
with HIV-1 according to DHCS during the 10-year period
from 1 January 1995 to 31 December 2004. Baseline char-
acteristics are shown in Table 1. Of these, a total of 2,006
(99%) were registered in DNHR with HIV (Table 2) and
1,888 (93%) were registered in DNHR within one year of
the first positive HIV-1 test (Figure 1). Twenty-four (1.2%)
patients were diagnosed with HIV in DNHR more than
one year before registration in DHCS. In the DHCS popu-
lation, 96% of patients were seen in one of the eight HIV
treatment centres within one year of HIV diagnosis.
Predictors of registration of HIV diagnosis in DNHR
Being diagnosed after 1 January 2000 or with a baseline
CD4 < 200 cells/µl or HIV-RNA >= 100,000 copies/ml
were associated with increased change of registration of
HIV diagnosis in DNHR, both in crude and adjusted anal-
yses (Table 3). In the adjusted analysis, female gender was
associated with an HIV diagnosis appearing earlier in
DNHR. Route of infection, age, race and treatment centre
did not have a major impact on the likelihood of being
registered in DNHR.
Kaplan-Meier curve of time to registration with an HIV diag-nosis in the Danish National Hosp tal Registry from the te of first HIV positi test, acc rding o he Danish HIV Cohort StudyFigure 1
Kaplan-Meier curve of time to registration with an 
HIV diagnosis in the Danish National Hospital Regis-
try from the date of first HIV positive test, according 
to the Danish HIV Cohort Study.Page 3 of 7
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To investigate the potential association between early reg-
istration in DNHR and mortality, we compared mortality
among patients with a diagnosis in DNHR within 3
months of a diagnosis in DHCS with mortality among
those diagnosed later. There was no statistically significant
difference in risk of death in the group registered early vs.
the group registered late (Figure 2, MRR = 0.87: 95% CI,
0.61 – 1.24).
Hepatitis B and C
Details of HBV and HCV registration in DNHR and DHCS
are provided in Table 2. Only 30 (23%) HIV patients doc-
umented to have chronic HBV in DHCS (n = 129), and
126 (48%) HIV patients documented to have HCV in
DHCS (n = 264) were registered with these diagnoses in
DNHR. Of note, 17 patients were registered with HBV
(ICD10: B18.0 and B18.1) and 8 with HCV (ICD10:
B18.2) in DNHR who did not have a corresponding
record in DHCS (table 2). Assuming that the correct num-
bers of HBV and HCV are 129 + 17 = 146 and 264 + 8 =
272, the positive predictive values of being registered with
HBV and HCV in DHCS were 0.88 and 0.97 and in DNHR
0.32 and 0.54 respectively.
In a sensitivity analysis, we categorized patients registered
with HBV or nonspecific hepatitis as diagnosed with HBV
and patients registered with HCV or nonspecific hepatitis
as diagnosed with HCV. However, even when these diag-
noses were combined, HBV and HCV remained incom-
pletely documented in DNHR compared to DHCS (Table
2).
The registration in DNHR of chronic hepatitis infections
for the 2,033 HIV patients in DHCS increased over time.
26% and 42% of all DHCS-established HBV and HCV
coinfections were registered in DNHR in the 1995–1999
period, versus 41% (p = 0.05) and 57% (p = 0.01), respec-
tively, for the 2000–2004 period.
Discussion
We found almost complete registration of HIV diagnoses
in DHNR. In contrast, co-infection with HBC and HCV
were poorly captured.
A unique opportunity to compare two independent,
nationwide registries of HIV infection allowed this study
to be undertaken. The population-based DHCS was used
as a reference to validate the number of HIV diagnoses in
DNHR. We documented that DNHR effectively captures
the diagnosis of HIV in all patients with at least one con-
tact with an HIV hospital treatment centre. The level of
completeness was close to 100%, with more than 90% of
patients registered in DNHR within a year of their first
HIV-positive test being documented in DHCS.
One study limitation is the unknown number of persons
diagnosed with HIV who have not sought hospital care.
Thus, while we can conclude that HIV patients with a hos-
Table 1: Characteristics of HIV patients registered in the Danish 
HIV Cohort Study.
Total number of patients 2,033
Male (%) 1,496 (73.6)
Age (years, median, IQR) 36.4 (30.1 – 44.8)
Race
Caucasian (%) 1,530 (75.3)
Black (%) 331 (16.3)
Asian (%) 111 (5.5)
Other and unknown (%) 61 (3.0)
Route of infection
Homosexual (%) 822 (40.4)
Heterosexual (%) 908 (44.7)
Intravenous drug use (%) 180 (8.9)
Other/unknown (%) 123 (6.1)
CD4 count/ul at diagnosis (median, IQR) 290 (110 – 490)
Log (HIV-RNA/ml) at diagnosis (median, IQR) 4.71 (3.97 – 5.30)
Table 2: Registrations of HIV, chronic hepatitis B, and chronic hepatitis C infections in the Danish National Hospital Registry (DNHR) 
for 2,033 HIV patients identified in the Danish HIV Cohort Study (DHCS).
Registered with the disease 
in DHCS and DNHR
Registered with the disease 
in DHCS but not in DNHR
Registered with the disease 
in DNHR but not in DHCS
Not registered with the 
disease in either DHCS or 
DNHR
HIV 2,006 (99%) 27 (1%) Not applicable Not applicable
Chronic hepatitis B (B18.0, 
B18.1)*
30 (23%) 99 (77%) 17 1,887
Chronic hepatitis B 
including B18.8 and B18.9*
42 (33%) 87 (67%) 30 1,874
Chronic hepatitis C 
(B18.2)*
126 (48%) 138 (52%) 8 1,761
Chronic hepatitis C 
including B18.8 and B18.9*
129 (49%) 135 (51%) 28 1,741
*Refers to the ICD-10 codes used to identify patients in DNHR.
The percentage is based on the total number of patients registered in DHCS.Page 4 of 7
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characteristics and treatment centre.
Crude HR (95% CI) Adjusted HR (95% CI)
Male gender (reference) 1 1
Female gender 1.05 (0.95–1.16) 1.15 (1.02–1.30)
Caucasian (reference) 1 1
Non-Caucasian 1.02 (0.92–1.13) 0.93 (0.82–1.05)
Age > 40 years (vs. <= 40 years) 1.12 (1.02–1.22) 1.07 (0.97–1.18)
CD4 count < 200 cells/µl (vs. ≥ 200 cell/µl) 1.45 (1.32–1.59) 1.38 (1.25–1.52)
Viral load > 100,000 copies/ml (vs. ≤ 100,000 copies/ml) 1.32 (1.21–1.45) 1.14 (1.03–1.26)
Heterosexual (reference) 1 1
Homosexual 1.01 (0.92–1.11) 1.04 (0.93–1.17)
Intravenous drug use 0.85 (0.72–1.00) 0.87 (0.73–1.04)
Other/unknown 1.05 (0.86–1.27) 1.07 (0.88–1.31)
Diagnosed before year 2000 (reference) 1 1
Diagnosed after 1 January 2000 1.40 (1.28–1.53) 1.40 (1.28–1.53)
Centre
Center 1 1 1
Center 2 1.03 (0.93–1.14) 1.06 (0.95–1.17)
Center 3 1.08 (0.91–1.27) 1.12 (0.94–1.32)
Center 4 0.87 (0.75–1.02) 0.91 (0.78–1.07)
Center 5–8* 0.99 (0.86–1.15) 0.98 (0.83–1.14)
* The four smallest centers in the Danish HIV Cohort Study (DHCS)
pital contact are captured by DNHR, we cannot use DNHR
to determine the total number of Danish patients diag-
nosed with HIV. However, as nearly 95% of the patients
in DHCS are seen in an HIV treatment centre within a year
of HIV diagnosis, we assume that this bias is small.
Twenty-four patients had a HIV diagnosis captured in the
DNHR more than one year before registration in DHCS.
This is not surprising, as clinical experience shows that not
all patients disclose a previous HIV diagnosis when they
present to an HIV treatment centre. Also some of these
patients may be misclassified in DHCS.
As mentioned, we did not have permission to identify HIV
cases recorded only in DNHR, and thus it was not within
the aim of this study to validate the predictive value of an
HIV-diagnosis recorded in DNHR. We consider this an
acceptable limitation as the positive predicted value is
expected to be high. HIV is unambiguously diagnosed by
presence of specific antibodies detected by well-validated
assay and reports of patients falsely diagnosed with HIV in
Danish Hospitals are extremely rare.
Registration of HIV in DNHR was influenced slightly by
demographic and HIV-associated factors. Thus, patients
with signs of more advanced HIV disease (higher viral
load and lower CD4 count at presentation), and patients
diagnosed in later years were more likely to be registered
in DNHR. Because very few HIV patients are not registered
in DNHR, this bias should have little influence on esti-
mates of disease severity based on data from DNHR. Of
not, there was no significant differences in mortality in
patients registered late compared with patients registered
early in DNHR indicating that the probability of being
registered in DNHR is not associated with risk of subse-
quent death.
Kaplan-Meier curve of the time to death for patients with di gnoses r gistered early in the Danish National Hosp al Re istry [within 3 m nt s of HIV di gnosis in the Danish HIV Cohort Study] [b ok n line] and for patients diag o ed l ter(after 3 months) [solid line]Figure 2
Kaplan-Meier curve of the time to death for patients 
with diagnoses registered early in the Danish 
National Hospital Registry [within 3 months of HIV 
diagnosis in the Danish HIV Cohort Study] [broken 
line] and for patients diagnosed later (after 3 
months) [solid line].Page 5 of 7
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completeness of registration in hospital databases of acute
myocardial infarction, severe bacterial infections, cancer,
and major surgical procedures [13-16]. These conditions
are all rather easily and unambiguously diagnosed and
have important treatment indications.
In contrast to HIV, HBV and HCV were incompletely reg-
istered in DNHR and registration trends varied greatly
over time. Thus, DNHR is a poor tool for determining
both absolute and relative risks of HBV and HCV among
HIV-positive persons. There are many potential explana-
tions for this finding. Chronic HBV and HCV are often
diagnosed after routine screening, are mainly asympto-
matic and do not always require treatment [17,18]. Thus
HBV and HCV infection may not be an important focus of
personnel coding discharge diagnoses. The importance of
completeness of data on HCV infection is exemplified in
a French study that clearly demonstrated that missing
diagnosis of HCV (in this study by lack of HIV serology)
introduced considerable bias into a cohort study of HIV
and HCV coinfection [19].
Our study makes clear that while DNHR generally has
good coverage, the completeness of some specific diag-
noses may be insufficient for valid epidemiological
research. As important examples, HBV and HCV infec-
tions are typically diagnosed secondary to the primary
HIV diagnosis and are often missing from DNHR.
This validation study was conducted in a Danish setting.
Given the nature of HIV infection, its results may be gen-
eralised to other countries with similarly organised health
care systems such as other Scandinavian countries.
Conclusion
In conclusion, our study confirms the importance of con-
sidering the quality of available data and the circum-
stances under which they are collected before conducting
registry-based studies. While HIV infection can be accu-
rately identified using secondary data in registry-based
studies, medical records or other data sources may be
needed to identify specific comorbidities.
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